Perspective · 29 Jan 2025
CommentaryPublished 16 Nov 2020
PCSK9 Inhibitors or Ezetimibe as the Second Line Add-on to Statin Therapy
Subjects
General & Internal MedicineMore from this journal
The newest in Archives of Medicine.
Perspective · 29 Jan 2025
Early-life nutrition and its impact on pediatric immune development
Commentary · 29 Jan 2025
Polypharmacy in the aging population: Risks, benefits and alternatives
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives of Medicine
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Aniruddha Singh”
